🔴 MDxHealth is trading 6.25% down in pre-market with no company-specific explanation identified

MDxHealth is trading at $0.18, down 6.25%, with no new company announcement identified to explain the October 29 pre-market move.

• Latest identified company-specific news was October 15: MDxHealth projected preliminary Q3 revenue of $22.7 million and suspended its $110–115 million full-year revenue guidance.
• Nasdaq futures were down 1.30%, a possible broader risk-off backdrop, but no direct link to MDxHealth is established.
• No pre-market volume or activity data was available.